Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Edelmann

Showing results (91-100 of 218) with videos related to

Pageof 22
Sort By:
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|June 1, 2022
Prevalence and prognostic impact of chronic kidney disease and anaemia across ACC/AHA precursor and symptomatic heart failure stagesLouisa M S Gerhardt, Maren Kordsmeyer, Susanne Sehner, et al.
ESC Heart Failure|August 18, 2022
Nitric oxide metabolites: associations with cardiovascular biomarkers and clinical parameters in patients with HFpEFKarsten Piatek, Anna Feuerstein, Veronika Zach, et al.
European Journal of Internal Medicine|February 5, 2013
Determinants of change in quality of life in the Cardiac Insufficiency Bisoprolol Study in Elderly (CIBIS-ELD)Martin Scherer, Hans-Dirk Düngen, Simone Inkrot, et al.
Stroke|October 15, 2011
Transthoracic echocardiography to rule out paroxysmal atrial fibrillation as a cause of stroke or transient ischemic attackRaoul Stahrenberg, Frank Edelmann, Beatrice Haase, et al.
ESC Heart Failure|February 10, 2021
The diagnostic and prognostic value of galectin-3 in patients at risk for heart failure with preserved ejection fraction: results from the DIAST-CHF studyTobias Daniel Trippel, Meinhard Mende, Hans-Dirk Düngen, et al.
ESC Heart Failure|February 21, 2019
Vitamin D deficiency in patients with diastolic dysfunction or heart failure with preserved ejection fractionKathleen Nolte, Christoph Herrmann-Lingen, Lars Platschek, et al.
European Journal of Heart Failure|May 1, 2018
Biomarker-based phenotyping of myocardial fibrosis identifies patients with heart failure with preserved ejection fraction resistant to the beneficial effects of spironolactone: results from the Aldo-DHF trialSusana Ravassa, Tobias Trippel, Doris Bach, et al.
Stroke|October 23, 2010
Enhanced detection of paroxysmal atrial fibrillation by early and prolonged continuous holter monitoring in patients with cerebral ischemia presenting in sinus rhythmRaoul Stahrenberg, Mark Weber-Krüger, Joachim Seegers, et al.
Cells|October 23, 2021
Plasma Biomarker Profiling in Heart Failure Patients with Preserved Ejection Fraction before and after Spironolactone Treatment: Results from the Aldo-DHF TrialMoritz Schnelle, Andreas Leha, Abass Eidizadeh, et al.
ESC Heart Failure|January 6, 2022
Left atrial strain predicts exercise capacity in heart failure independently of left ventricular ejection fractionCaterina Maffeis, Andrea Rossi, Lorenzo Cannata, et al.
Pageof 22

Showing results (91-100 of 218) with videos related to

Sort By:
Pageof 22
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|June 1, 2022
Prevalence and prognostic impact of chronic kidney disease and anaemia across ACC/AHA precursor and symptomatic heart failure stagesLouisa M S Gerhardt, Maren Kordsmeyer, Susanne Sehner, et al.
ESC Heart Failure|August 18, 2022
Nitric oxide metabolites: associations with cardiovascular biomarkers and clinical parameters in patients with HFpEFKarsten Piatek, Anna Feuerstein, Veronika Zach, et al.
European Journal of Internal Medicine|February 5, 2013
Determinants of change in quality of life in the Cardiac Insufficiency Bisoprolol Study in Elderly (CIBIS-ELD)Martin Scherer, Hans-Dirk Düngen, Simone Inkrot, et al.
Stroke|October 15, 2011
Transthoracic echocardiography to rule out paroxysmal atrial fibrillation as a cause of stroke or transient ischemic attackRaoul Stahrenberg, Frank Edelmann, Beatrice Haase, et al.
ESC Heart Failure|February 10, 2021
The diagnostic and prognostic value of galectin-3 in patients at risk for heart failure with preserved ejection fraction: results from the DIAST-CHF studyTobias Daniel Trippel, Meinhard Mende, Hans-Dirk Düngen, et al.
ESC Heart Failure|February 21, 2019
Vitamin D deficiency in patients with diastolic dysfunction or heart failure with preserved ejection fractionKathleen Nolte, Christoph Herrmann-Lingen, Lars Platschek, et al.
European Journal of Heart Failure|May 1, 2018
Biomarker-based phenotyping of myocardial fibrosis identifies patients with heart failure with preserved ejection fraction resistant to the beneficial effects of spironolactone: results from the Aldo-DHF trialSusana Ravassa, Tobias Trippel, Doris Bach, et al.
Stroke|October 23, 2010
Enhanced detection of paroxysmal atrial fibrillation by early and prolonged continuous holter monitoring in patients with cerebral ischemia presenting in sinus rhythmRaoul Stahrenberg, Mark Weber-Krüger, Joachim Seegers, et al.
Cells|October 23, 2021
Plasma Biomarker Profiling in Heart Failure Patients with Preserved Ejection Fraction before and after Spironolactone Treatment: Results from the Aldo-DHF TrialMoritz Schnelle, Andreas Leha, Abass Eidizadeh, et al.
ESC Heart Failure|January 6, 2022
Left atrial strain predicts exercise capacity in heart failure independently of left ventricular ejection fractionCaterina Maffeis, Andrea Rossi, Lorenzo Cannata, et al.
Pageof 22